Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease aspergillosis
Phenotype C0004096|asthma
Sentences 15
PubMedID- 19207831 Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in patients with acute severe asthma in a respiratory intensive care unit in north india.
PubMedID- 25620428 The diagnostic criteria for allergic bronchopulmonary aspergillosis in children with poorly controlled asthma need to be re-evaluated.
PubMedID- 25354514 Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated.
PubMedID- 22794691 Allergic bronchopulmonary aspergillosis (abpa) occurs in patients with asthma or cystic fibrosis resulting in pulmonary infiltrates, tenacious mucus plugs that harbor hyphae of aspergillus fumigatus, elevations of total serum ige concentration and peripheral blood, and sputum eosinophilia.
PubMedID- 23750172 Allergic bronchopulmonary aspergillosis affects patients with asthma and bronchiectasis.
PubMedID- 23210682 Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults.
PubMedID- 23827645 Background and objective: the prevalence of allergic bronchopulmonary aspergillosis (abpa) in patients with bronchial asthma remains unknown.
PubMedID- 24748808 Thus, although ige levels may be helpful in the diagnosis of allergic bronchopulmonary aspergillosis, with features of asthma and eosinophilia, the total ige has little utility in evaluation of most patients with asthma.
PubMedID- 26265625 Integrated therapy for invasive pulmonary aspergillosis in a patient with asthma and chronic obstructive pulmonary disease overlap syndrome.
PubMedID- 26187954 Allergic bronchopulmonary aspergillosis affects patients with asthma and cystic fibrosis, and is important to recognise as permanent lung or airways damage may accrue if untreated.
PubMedID- 22794704 Total serum ige can be measured and is helpful in determining atopic presentations such as in allergic bronchopulmonary aspergillosis or in patients with persistent asthma who are candidates for monoclonal anti-ige antibody therapy with, omalizumab.
PubMedID- 25125809 [4] allergic aspergillosis clinically presents with poorly controlled asthma, fleeting pulmonary opacities and bronchiectasis.
PubMedID- 25705310 asthma with allergic bronchopulmonary aspergillosis (abpa), a hypersensitivity disease of the lungs due to an immune response to aspergillus fumigattus (af) antigens, is rarely seen in children, other than complicating cystic fibrosis.
PubMedID- 21402950 Aspergillus fumigatus is commonly associated with allergic bronchopulmonary aspergillosis in patients with severe asthma in which chronic airway neutrophilia predicts a poor outcome.
PubMedID- 21603163 Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis.

Page: 1